MEVALOTIN Side Effects

5971484-2 | Hepatitis Fulminant, Renal Failure Acute
on Nov 20, 2008 Male patient from JAPAN , 65 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: hepatitis fulminant, renal failure acute. Mevalotin dosage: . During the same period patient was treated with ACTOS (View Actos Review and Actos Label ), MICARDIS (View Micardis Review and Micardis Label ), NORVASC (View Norvasc Review and Norvasc Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ), AMARYL (View Amaryl Review and Amaryl Label ), BASEN (Basen Od) (View Basen Review and Basen Label ), EPADEL (View Epadel Review and Epadel Label ).

5809480-8 | C-reactive Protein Increased, Headache, Liver Disorder
Patient was taking Mevalotin (View Usage). Patient had the following side effects: c-reactive protein increased, headache (What is headache?), liver disorder on Jul 08, 2008 from JAPAN Additional patient health information: Male patient , 64 years of age, was diagnosed with hyperlipidaemia, rheumatoid arthritis (What is rheumatoid arthritis?) and. Mevalotin dosage: . During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), SELBEX (Restarted-07may08; 50mg 3 In 1 Day.) (View Selbex Review and Selbex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), GASTER (Interrupted On 2005,restarted On 07-may-2008.) (View Gaster Review and Gaster Label ). Patient was hospitalized.

5804666-0 | Leukopenia
Adverse event was reported on Jul 03, 2008 by a Female patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, hypertension, back pain (What is back pain?) and. Location: JAPAN , 83 years of age, After Mevalotin was administered, patient had the following side effects: leukopenia. During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), LOXONIN (View Loxonin Review and Loxonin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ), BONALON (View Bonalon Review and Bonalon Label ), JUVELA N (View Juvela N Review and Juvela N Label ), CONIEL (View Coniel Review and Coniel Label ), MUCOSTA (View Mucosta Review and Mucosta Label ). Patient was hospitalized.

5782014-2 | Platelet Count Decreased
on Jun 13, 2008 Female patient from JAPAN , 75 years of age, was diagnosed with hypercholesterolaemia and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: platelet count decreased. Mevalotin dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), BASEN (View Basen Review and Basen Label ), LANSOPRAZOLE (View Lansoprazole Review and Lansoprazole Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HERBAL MIXTURE (View Herbal Mixture Review and Herbal Mixture Label ).


5760687-8 | Headache, Liver Disorder
on May 29, 2008 Male patient from JAPAN , 64 years of age, was diagnosed with hyperlipidaemia, rheumatoid arthritis (What is rheumatoid arthritis?) and was treated with Mevalotin (View Usage). Patient had the following side effects: headache (What is headache?), liver disorder. Mevalotin dosage: . During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), SELBEX (Restarted On 6-may-2008) (View Selbex Review and Selbex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), FAMOTIDINE (Interrupted On 2005,restarted On 09-may-2008.) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5746258-8 | Platelet Count Decreased
Patient was taking Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: platelet count decreased on May 16, 2008 from JAPAN Additional patient health information: Female patient , 75 years of age, was diagnosed with hypercholesterolaemia and. Mevalotin dosage: . During the same period patient was treated with AMARYL (View Amaryl Review and Amaryl Label ), BASEN (View Basen Review and Basen Label ), TAKEPRON (View Takepron Review and Takepron Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), HERBAL MIXTURE (View Herbal Mixture Review and Herbal Mixture Label ).

5745071-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased
Adverse event was reported on May 15, 2008 by a Male patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with lipids abnormal and. Location: JAPAN , 64 years of age, Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased. During the same period patient was treated with RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), SELBEX (Interrupted On 2005.restarted On 01may08.) (View Selbex Review and Selbex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), FAMOTIDINE (Interrupted On 2005,restarted On 09-may-2008.) (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5739270-6 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, C-reactive Protein Increased
on May 08, 2008 Male patient from JAPAN , 64 years of age, was treated with Mevalotin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, c-reactive protein increased. Mevalotin dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), RHEUMATREX (View Rheumatrex Review and Rheumatrex Label ), FOLIAMIN (View Foliamin Review and Foliamin Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ). Patient was hospitalized.

5701859-8 | Cerebral Infarction, Rhabdomyolysis
on Mar 31, 2008 Female patient from JAPAN , 65 years of age, was diagnosed with hyperlipidaemia, systemic lupus erythematosus, osteoporosis (What is osteoporosis?), cerebral infarction, hypertension and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: cerebral infarction, rhabdomyolysis. Mevalotin dosage: . During the same period patient was treated with PREDONINE (View Predonine Review and Predonine Label ), BONALON (View Bonalon Review and Bonalon Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), MUCOSTA (View Mucosta Review and Mucosta Label ), ADALAT (View Adalat Review and Adalat Label ), PROGRAF (View Prograf Review and Prograf Label ), ALOSENN (View Alosenn Review and Alosenn Label ), SERENAL (View Serenal Review and Serenal Label ). Patient was hospitalized.

5659540-X | Asthenia, Asthma, Cerebral Arteriosclerosis, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension, Vasculitis
Patient was taking Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, asthma (What is asthma?), cerebral arteriosclerosis, cerebral infarction, computerised tomogram abnormal, gait disturbance, hypertension, vasculitis (What is vasculitis?) on Feb 29, 2008 from JAPAN Additional patient health information: Female patient , 63 years of age, weighting 121.3 lb, was diagnosed with hypertension and. Mevalotin dosage: 10 Mg, Unk. During the same period patient was treated with PARIET (10 Mg, Unk) (View Pariet Review and Pariet Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (15 Mg, Unk) (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ), SEREVENT (100 Ug) (View Serevent Review and Serevent Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), LOXONIN (180 Mg, Unk) (View Loxonin Review and Loxonin Label ), KIPRES (10 Mg, Unk) (View Kipres Review and Kipres Label ). Patient was hospitalized.

5638166-8 | Musculoskeletal Pain, Oedema Peripheral, Rhabdomyolysis
Adverse event was reported on Feb 15, 2008 by a Female patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, hypertension, analgesia, neuropathy peripheral and. Location: JAPAN , 77 years of age, Patient had the following side effects: musculoskeletal pain, oedema peripheral, rhabdomyolysis. During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALMARL (View Almarl Review and Almarl Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5625517-3 | Asthenia, Asthma, Cerebral Arteriosclerosis, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension, Vasculitis
on Feb 07, 2008 Female patient from JAPAN , 63 years of age, weighting 121.3 lb, was diagnosed with hypertension and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: asthenia, asthma (What is asthma?), cerebral arteriosclerosis, cerebral infarction, computerised tomogram abnormal, gait disturbance, hypertension, vasculitis (What is vasculitis?). Mevalotin dosage: 10 Mg, Unk. During the same period patient was treated with PARIET (10 Mg, Unk) (View Pariet Review and Pariet Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (15 Mg, Unk) (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ), SEREVENT (100 Ug) (View Serevent Review and Serevent Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), LOXONIN (180 Mg, Unk) (View Loxonin Review and Loxonin Label ), KIPRES (10 Mg, Unk) (View Kipres Review and Kipres Label ). Patient was hospitalized.

5625298-3 | Asthenia, Asthma, Cerebral Arteriosclerosis, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension, Vasculitis
on Feb 07, 2008 Female patient from JAPAN , 63 years of age, weighting 121.3 lb, was diagnosed with hypertension and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: asthenia, asthma (What is asthma?), cerebral arteriosclerosis, cerebral infarction, computerised tomogram abnormal, gait disturbance, hypertension, vasculitis (What is vasculitis?). Mevalotin dosage: 10 Mg, Unk. During the same period patient was treated with PARIET (10 Mg, Unk) (View Pariet Review and Pariet Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (15 Mg, Unk) (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ), SEREVENT (100 Ug) (View Serevent Review and Serevent Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), LOXONIN (180 Mg, Unk) (View Loxonin Review and Loxonin Label ), KIPRES (10 Mg, Unk) (View Kipres Review and Kipres Label ). Patient was hospitalized.

5611097-5 | Musculoskeletal Pain, Oedema Peripheral, Rhabdomyolysis
Patient was taking Mevalotin (View Usage). Patient had the following side effects: musculoskeletal pain, oedema peripheral, rhabdomyolysis on Jan 28, 2008 from JAPAN Additional patient health information: Female patient , 77 years of age, was diagnosed with hyperlipidaemia, hypertension and. Mevalotin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALMARL (View Almarl Review and Almarl Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5604748-2 | Asthenia, Asthma, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension, No Therapeutic Response, Vasculitis
Adverse event was reported on Jan 18, 2008 by a Female patient taking Mevalotin (View Usage) (Dosage: 10 Mg, Unk) was diagnosed with hypertension and. Location: JAPAN , 63 years of age, weighting 121.3 lb, After Mevalotin was administered, patient had the following side effects: asthenia, asthma (What is asthma?), cerebral infarction, computerised tomogram abnormal, gait disturbance, hypertension, no therapeutic response, vasculitis (What is vasculitis?). During the same period patient was treated with RABEPRAZOLE SODIUM (10 Mg, Unk) (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), GASMOTIN (15 Mg, Unk) (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (15 Mg, Unk) (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ), SEREVENT (100 Ug) (View Serevent Review and Serevent Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ), LOXONIN (180 Mg, Unk) (View Loxonin Review and Loxonin Label ), KIPRES (10 Mg, Unk) (View Kipres Review and Kipres Label ). Patient was hospitalized.

5598728-3 | Chromaturia, Musculoskeletal Pain, Oedema Peripheral, Rhabdomyolysis
on Jan 10, 2008 Female patient from JAPAN , 77 years of age, was diagnosed with hyperlipidaemia, hypertension and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: chromaturia, musculoskeletal pain, oedema peripheral, rhabdomyolysis. Mevalotin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALMARL (View Almarl Review and Almarl Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5598582-X | Electrocardiogram Qt Prolonged, Haemorrhage Subcutaneous, Pancytopenia
on Jan 11, 2008 Female patient from JAPAN , 87 years of age, was diagnosed with cerebrovascular disorder and was treated with Mevalotin (View Usage). Patient had the following side effects: electrocardiogram qt prolonged, haemorrhage subcutaneous, pancytopenia. Mevalotin dosage: 10 Mg. During the same period patient was treated with ALLOPURINOL (100 Mg) (View Allopurinol Review and Allopurinol Label ), MEDITRANS (View Meditrans Review and Meditrans Label ), TAKEPRON OD (View Takepron Od Review and Takepron Od Label ), LASIX (View Lasix Review and Lasix Label ), D ALFA (View D-alfa Review and D-alfa Label ), PLAVIX (View Plavix Review and Plavix Label ).

5580535-9 | Asthenia, Asthma, Cerebral Infarction, Computerised Tomogram Abnormal, Gait Disturbance, Hypertension
Patient was taking Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: asthenia, asthma (What is asthma?), cerebral infarction, computerised tomogram abnormal, gait disturbance, hypertension on Dec 26, 2007 from JAPAN Additional patient health information: Female patient , 63 years of age, was diagnosed with hypertension and. Mevalotin dosage: . During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ), SEREVENT (View Serevent Review and Serevent Label ), PREDNISOLONE (20 Mg, Unk) (View Prednisolone Review and Prednisolone Label ), SALMETEROL XINAFOATE (View Salmeterol Xinafoate Review and Salmeterol Xinafoate Label ). Patient was hospitalized.

5572788-8 | Asthma, Cerebral Infarction, Computerised Tomogram Abnormal
Adverse event was reported on Dec 14, 2007 by a Female patient taking Mevalotin (View Usage) (Dosage: ) . Location: JAPAN , 63 years of age, Patient experienced the following unwanted or unexpected effects: asthma (What is asthma?), cerebral infarction, computerised tomogram abnormal. During the same period patient was treated with RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), GASMOTIN (View Gasmotin Review and Gasmotin Label ), PRIMPERAN INJ (View Primperan Inj Review and Primperan Inj Label ), DIOVAN (80 Mg, Qd) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5568195-4 | Chromaturia, Musculoskeletal Pain, Oedema Peripheral, Rhabdomyolysis
on Dec 12, 2007 Female patient from JAPAN , 76 years of age, was diagnosed with hyperlipidaemia, hypertension and was treated with Mevalotin (View Usage). Patient had the following side effects: chromaturia, musculoskeletal pain, oedema peripheral, rhabdomyolysis. Mevalotin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALMARL (View Almarl Review and Almarl Label ), LOXONIN (View Loxonin Review and Loxonin Label ), CYANOCOBALAMIN (View Cyanocobalamin Review and Cyanocobalamin Label ). Patient was hospitalized.

5553406-1 | Chromaturia, Musculoskeletal Pain, Oedema Peripheral
on Dec 07, 2007 Female patient from JAPAN , 76 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: chromaturia, musculoskeletal pain, oedema peripheral. Mevalotin dosage: . During the same period patient was treated with DIOVAN (View Diovan Review and Diovan Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALMARL (View Almarl Review and Almarl Label ).

5523207-9 |
Patient was taking Mevalotin (View Usage). on Nov 15, 2007 from JAPAN Additional patient health information: Female patient , 76 years of age, . Mevalotin dosage: . During the same period patient was treated with SERMION (View Sermion Review and Sermion Label ), AMOBAN (View Amoban Review and Amoban Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), BUP 4 (View Bup-4 Review and Bup-4 Label ).

5516833-4 |
Adverse event was reported on Nov 13, 2007 by a Female patient taking Mevalotin (View Usage) (Dosage: ) . Location: JAPAN , 76 years of age, . During the same period patient was treated with SERMION (View Sermion Review and Sermion Label ), AMOBAN (View Amoban Review and Amoban Label ), TETRAMIDE (View Tetramide Review and Tetramide Label ), RISPERDAL (View Risperdal Review and Risperdal Label ), BUP 4 (View Bup-4 Review and Bup-4 Label ).

5383076-7 | Liver Disorder, Liver Function Test Abnormal, Urine Abnormality
on Jun 29, 2007 Female patient from JAPAN , 43 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: liver disorder, liver function test abnormal, urine abnormality. Mevalotin dosage: . During the same period patient was treated with BOUFUUTSUUSHOUSAN (View Boufuutsuushousan Review and Boufuutsuushousan Label ), FLOMOX (View Flomox Review and Flomox Label ).

5373226-0 | Gastroenteritis
on Jun 20, 2007 Female patient from JAPAN , 83 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?). Mevalotin dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LUPRAC (View Luprac Review and Luprac Label ), ARICEPT (View Aricept Review and Aricept Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIOVAN (40 Mg/daily) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5366427-9 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased, Eosinophil Count Decreased, Myalgia, Myoglobin Blood Increased
Patient was taking Mevalotin (View Usage). Patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased, eosinophil count decreased, myalgia, myoglobin blood increased on Jun 15, 2007 from JAPAN Additional patient health information: Male patient , 49 years of age, was diagnosed with hyperlipidaemia, cerebral infarction, nail tinea and. Mevalotin dosage: 10 Mg/day. During the same period patient was treated with TAGAMET (400 Mg/day) (View Tagamet Review and Tagamet Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), SERMION (15 Mg/day) (View Sermion Review and Sermion Label ), LAMISIL (125 Mg, Qd) (View Lamisil Review and Lamisil Label ), WARFARIN SODIUM (3 Mg, Unk) (View Warfarin Sodium Review and Warfarin Sodium Label ), LANOCONAZOLE (View Lanoconazole Review and Lanoconazole Label ).

5347246-6 | Blood Creatine Phosphokinase Increased
Adverse event was reported on May 28, 2007 by a Male patient taking Mevalotin (View Usage) (Dosage: 10 Mg/day) was diagnosed with hyperlipidaemia, cerebral infarction, nail tinea and. Location: JAPAN , 49 years of age, After Mevalotin was administered, patient had the following side effects: blood creatine phosphokinase increased. During the same period patient was treated with TAGAMET (400 Mg/day) (View Tagamet Review and Tagamet Label ), ASPIRIN (100 Mg/day) (View Aspirin Review and Aspirin Label ), SERMION (15 Mg/day) (View Sermion Review and Sermion Label ), LAMISIL (125 Mg/day) (View Lamisil Review and Lamisil Label ).

5279372-4 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased
on Mar 22, 2007 Male patient from JAPAN , 40 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood creatine phosphokinase increased, blood lactate dehydrogenase increased. Mevalotin dosage: .

5264220-9 | Abnormal Sensation In Eye, Eye Irritation, Eye Pain, Visual Field Defect
on Mar 01, 2007 Female patient from SWITZERLAND , 63 years of age, was diagnosed with polyneuropathy and was treated with Mevalotin (View Usage). Patient had the following side effects: abnormal sensation in eye, eye irritation, eye pain, visual field defect. Mevalotin dosage: Unk. During the same period patient was treated with COVERSUM (Unk) (View Coversum Review and Coversum Label ), NEBILET (View Nebilet Review and Nebilet Label ), LYRICA (150 Mg) (View Lyrica Review and Lyrica Label ), LEXOTANIL (View Lexotanil Review and Lexotanil Label ), ZOLPIDEM TARTRATE (View Zolpidem Tartrate Review and Zolpidem Tartrate Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ELTROXIN (View Eltroxin Review and Eltroxin Label ).

5234502-5 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Fatigue, Gamma-glutamyltransferase Increased, Hepatic Function Abnormal, Liver Disorder, Pneumonia
Patient was taking Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, fatigue, gamma-glutamyltransferase increased, hepatic function abnormal, liver disorder, pneumonia (What is pneumonia?) on Jan 24, 2007 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hyperlipidaemia, gastritis, enterocolitis and. Mevalotin dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), BIO THREE (View Bio-three Review and Bio-three Label ). Patient was hospitalized.

5197921-1 | Gastroenteritis
Adverse event was reported on Dec 28, 2006 by a Female patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hypertension and. Location: JAPAN , 83 years of age, weighting 123.5 lb, Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?). During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LUPRAC (View Luprac Review and Luprac Label ), ARICEPT (View Aricept Review and Aricept Label ), ALLOPURINOL TAB (View Allopurinol Tab Review and Allopurinol Tab Label ), DIOVAN (40 Mg/daily) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5196045-7 | Blood Creatine Phosphokinase Increased
on Dec 19, 2006 Female patient from JAPAN , 63 years of age, was treated with Mevalotin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased. Mevalotin dosage: .

5182674-3 | Acute Respiratory Distress Syndrome, Interstitial Lung Disease
on Nov 28, 2006 Male patient from JAPAN , 61 years of age, was diagnosed with hyperlipidaemia, hypertension, gastric ulcer, dysthymic disorder, nasopharyngitis and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: acute respiratory distress syndrome, interstitial lung disease. Mevalotin dosage: . During the same period patient was treated with OLMETEC (View Olmetec Review and Olmetec Label ), ZANTAC (View Zantac Review and Zantac Label ), NORVASC (View Norvasc Review and Norvasc Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), NICHOLASE (View Nicholase Review and Nicholase Label ), HUSCODE (View Huscode Review and Huscode Label ).

5173354-9 | Liver Disorder, Pneumonia
Patient was taking Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: liver disorder, pneumonia (What is pneumonia?) on Oct 17, 2006 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hyperlipidaemia, gastritis, enterocolitis and. Mevalotin dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), BIO THREE (View Bio-three Review and Bio-three Label ). Patient was hospitalized.

5168937-6 | Interstitial Lung Disease
Adverse event was reported on Nov 28, 2006 by a Male patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, hypertension, nasopharyngitis and. Location: JAPAN , 61 years of age, Patient had the following side effects: interstitial lung disease. During the same period patient was treated with OLMETEC (View Olmetec Review and Olmetec Label ), ZANTAC (View Zantac Review and Zantac Label ), NORVASC (View Norvasc Review and Norvasc Label ), ETIZOLAM (View Etizolam Review and Etizolam Label ), NICHOLASE (View Nicholase Review and Nicholase Label ), HUSCODE (View Huscode Review and Huscode Label ). Patient was hospitalized.

5168442-7 | Aspartate Aminotransferase Increased, Asthenia, Blood Creatine Phosphokinase Increased, Blood Lactate Dehydrogenase Increased
on Nov 24, 2006 Male patient from JAPAN , 40 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: aspartate aminotransferase increased, asthenia, blood creatine phosphokinase increased, blood lactate dehydrogenase increased. Mevalotin dosage: . Patient was hospitalized.

5163289-X | Gastroenteritis
on Nov 21, 2006 Female patient from JAPAN , 83 years of age, weighting 123.5 lb, was diagnosed with hypertension and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: gastroenteritis (What is gastroenteritis?). Mevalotin dosage: . During the same period patient was treated with ADALAT (View Adalat Review and Adalat Label ), LIPITOR (View Lipitor Review and Lipitor Label ), LUPRAC (View Luprac Review and Luprac Label ), ARICEPT (View Aricept Review and Aricept Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), DIOVAN (40 Mg/daily) (View Diovan Review and Diovan Label ). Patient was hospitalized.

5134703-0 | Liver Disorder, Pneumonia
Patient was taking Mevalotin (View Usage). Patient had the following side effects: liver disorder, pneumonia (What is pneumonia?) on Oct 17, 2006 from JAPAN Additional patient health information: Male patient , 73 years of age, was diagnosed with hyperlipidaemia, gastritis, enterocolitis and. Mevalotin dosage: . During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), NIZATIDINE (View Nizatidine Review and Nizatidine Label ), BIO THREE (View Bio-three Review and Bio-three Label ). Patient was hospitalized.

5124243-7 | Hepatic Function Abnormal, Pneumonia
Adverse event was reported on Sep 26, 2006 by a Male patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, prophylaxis against gastrointestinal ulcer and. Location: JAPAN , 73 years of age, After Mevalotin was administered, patient had the following side effects: hepatic function abnormal, pneumonia (What is pneumonia?). During the same period patient was treated with SELBEX (View Selbex Review and Selbex Label ), BIO THREE (View Bio-three Review and Bio-three Label ). Patient was hospitalized.

5120980-9 | Cerebrovascular Accident, Vascular Dementia
on Sep 04, 2006 Female patient from JAPAN , 66 years of age, was diagnosed with hyperlipidaemia, hypertension, cerebral infarction and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: cerebrovascular accident, vascular dementia. Mevalotin dosage: . During the same period patient was treated with PLENDIL (View Plendil Review and Plendil Label ), BETALOC (View Betaloc Review and Betaloc Label ), TRADITIONAL CHINESE MEDICINE (View Traditional Chinese Medicine Review and Traditional Chinese Medicine Label ).

5037403-0 | Blood Creatine Phosphokinase Increased, Dyspepsia, Myalgia, Weight Increased
on Jun 16, 2006 Male patient from JAPAN , 53 years of age, was diagnosed with hyperlipidaemia, hypertension and was treated with Mevalotin (View Usage). Patient had the following side effects: blood creatine phosphokinase increased, dyspepsia, myalgia, weight increased. Mevalotin dosage: . During the same period patient was treated with ZOCOR (View Zocor Review and Zocor Label ), ASPIRIN (View Aspirin Review and Aspirin Label ). Patient was hospitalized.

4988421-X | Acute Sinusitis, Benign Prostatic Hyperplasia, Gastric Cancer, Gastroduodenal Ulcer, Renal Failure, Rhabdomyolysis
Patient was taking Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: acute sinusitis, benign prostatic hyperplasia, gastric cancer, gastroduodenal ulcer, renal failure, rhabdomyolysis on Mar 23, 2006 from JAPAN Additional patient health information: Male patient , 80 years of age, was diagnosed with hyperlipidaemia, benign prostatic hyperplasia, gastroduodenal ulcer, insomnia, acute sinusitis, constipation (What is constipation?) and. Mevalotin dosage: . During the same period patient was treated with PERSELIN (View Perselin Review and Perselin Label ), ACINON (View Acinon Review and Acinon Label ), HARNAL (View Harnal Review and Harnal Label ), SEDAPRAN (View Sedapran Review and Sedapran Label ), BANAN (View Banan Review and Banan Label ), MUCODYNE (View Mucodyne Review and Mucodyne Label ), EXCELASE (View Excelase Review and Excelase Label ), PURSENNID (View Pursennid Review and Pursennid Label ). Patient was hospitalized.

4972067-3 | Aplastic Anaemia, Platelet Count Decreased
Adverse event was reported on Feb 10, 2006 by a Female patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, rheumatoid arthritis (What is rheumatoid arthritis?), hypertension, mineral supplementation, constipation (What is constipation?) and. Location: JAPAN , 73 years of age, Patient experienced the following unwanted or unexpected effects: aplastic anaemia, platelet count decreased. During the same period patient was treated with RIMATIL (View Rimatil Review and Rimatil Label ), DIOVAN (View Diovan Review and Diovan Label ), ASPARA K (View Aspara-k Review and Aspara-k Label ), MAGMITT (View Magmitt Review and Magmitt Label ). Patient was hospitalized.

4968343-0 | Abdominal Distension, Arthralgia, Constipation, Dry Mouth
on Mar 24, 2006 Female patient from JAPAN , 42 years of age, was diagnosed with hyperlipidaemia and was treated with Mevalotin (View Usage). Patient had the following side effects: abdominal distension, arthralgia, constipation (What is constipation?), dry mouth. Mevalotin dosage: .

4954271-3 | Systemic Lupus Erythematosus
on Mar 15, 2006 Male patient from JAPAN , 78 years of age, was diagnosed with hyperlipidaemia, hypertension, diabetes mellitus and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: systemic lupus erythematosus. Mevalotin dosage: . During the same period patient was treated with TANATRIL (View Tanatril Review and Tanatril Label ), MICARDIS (View Micardis Review and Micardis Label ), BASEN (View Basen Review and Basen Label ). Patient was hospitalized.

4948222-5 | Pneumonia, Rhabdomyolysis
Patient was taking Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: pneumonia (What is pneumonia?), rhabdomyolysis on Feb 23, 2006 from JAPAN Additional patient health information: Male patient , 77 years of age, was diagnosed with hyperlipidaemia, hypertension, diabetes mellitus and. Mevalotin dosage: . During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), EUGLUCON (View Euglucon Review and Euglucon Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

4940094-8 | Aspartate Aminotransferase Increased, Blood Creatine Phosphokinase Increased, Pyrexia
Adverse event was reported on Feb 06, 2006 by a Male patient taking Mevalotin (View Usage) (Dosage: ) was diagnosed with hyperlipidaemia, hypertension, gastritis, cerebral infarction, diabetes mellitus and. Location: JAPAN , 64 years of age, Patient had the following side effects: aspartate aminotransferase increased, blood creatine phosphokinase increased, pyrexia. During the same period patient was treated with OLMETEC (View Olmetec Review and Olmetec Label ), CALBLOCK (View Calblock Review and Calblock Label ), KELNAC (View Kelnac Review and Kelnac Label ), PLETAL (View Pletal Review and Pletal Label ), INSULIN HUMAN (View Insulin Human Review and Insulin Human Label ).

4934114-4 | Blood Creatine Phosphokinase Increased, Chromaturia, Muscular Weakness
on Feb 23, 2006 Male patient from JAPAN , 77 years of age, was diagnosed with hyperlipidaemia, hypertension, diabetes mellitus and was treated with Mevalotin (View Usage). After Mevalotin was administered, patient had the following side effects: blood creatine phosphokinase increased, chromaturia, muscular weakness. Mevalotin dosage: . During the same period patient was treated with ACECOL (View Acecol Review and Acecol Label ), DILTIAZEM HCL (View Diltiazem Hcl Review and Diltiazem Hcl Label ), EUGLUCON (View Euglucon Review and Euglucon Label ), METFORMIN HCL (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

4924460-2 | Hypertension, Tinnitus, Vertigo
on Feb 23, 2006 Male patient from JAPAN , 58 years of age, was diagnosed with hyperlipidaemia, hypertension and was treated with Mevalotin (View Usage). Patient experienced the following unwanted or unexpected effects: hypertension, tinnitus (What is tinnitus?), vertigo. Mevalotin dosage: . During the same period patient was treated with FELODIPINE (View Felodipine Review and Felodipine Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), CLOPIDOGREL BISULFATE (View Clopidogrel Bisulfate Review and Clopidogrel Bisulfate Label ), LOTENSIN (View Lotensin Review and Lotensin Label ), BETALOC (View Betaloc Review and Betaloc Label ).

4921454-8 | Depressed Level Of Consciousness, Rhabdomyolysis
Patient was taking Mevalotin (View Usage). Patient had the following side effects: depressed level of consciousness, rhabdomyolysis on Dec 22, 2005 from JAPAN Additional patient health information: Female patient , 69 years of age, weighting 163.1 lb, was diagnosed with hyperlipidaemia, reflux oesophagitis, hyperuricaemia and. Mevalotin dosage: . During the same period patient was treated with PARIET (View Pariet Review and Pariet Label ), TOYOFAROL (View Toyofarol Review and Toyofarol Label ), SOLANAX (View Solanax Review and Solanax Label ), GASTER D (View Gaster D Review and Gaster D Label ), NORVASC (View Norvasc Review and Norvasc Label ), ALLOPURINOL (View Allopurinol Review and Allopurinol Label ), LIPOVAS (View Lipovas Review and Lipovas Label ), ALOSENN (View Alosenn Review and Alosenn Label ). Patient was hospitalized.